Humana Inc. (HUM)$307.95
Market Cap: 30.98 BCurrency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for Humana Inc. (HUM).
HEALTHCARE
HEALTHCARE PLANS
DCF ready
Valuation
71.4x
EV/FCF, 1.4% FCF yield
Quality
6.7%
ROIC, 0.3% FCF margin
Growth
10.9%
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 2.0x current ratio
Superinvestors
2
Top: Richard Pzena (3.1%)
Strengths to research
- Revenue compounded at 10.9% over five years.
- Debt/equity looks manageable at 0.0x.
- 10 annual periods are available for trend analysis.
Watchouts
- P/FCF is elevated at 82.6x.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for HUM.
Grade C
61
/ 100
Peer Comparison
Target stock against 6 market-cap comparable peers.
Heat map: red worst to green best
| HUM Target | Humana Inc. | $31.0B | 31.3x | 71.4x | 6.7% | 10.9% | 0.3% | N/A | -1.2x | N/A |
| CNC | Centene Corp. | $29.7B | -4.4x | 6.8x | -17.8% | 11.0% | 2.5% | 8.1% | N/A | N/A |
| MOH | Molina Healthcare Inc. | $17.3B | 20.6x | -20.6x | 11.6% | 18.5% | -1.4% | N/A | -4.4x | N/A |
| CVS | CVS Health Corp. | $84.7B | 67.1x | 9.8x | 2.4% | 8.4% | 1.9% | N/A | -0.9x | N/A |
| CI | Cigna Group | $89.8B | 12.9x | 8.6x | 14.3% | 11.4% | 3.5% | N/A | -0.6x | N/A |
| ELV | Elevance Health Inc. | $94.1B | 15.7x | 36.7x | 7.5% | 10.3% | 1.6% | N/A | 2.6x | N/A |
| OSCR | Oscar Health Inc. | $3.3B | -13.4x | 0.5x | -45.3% | N/A | 3701.9% | N/A | N/A | N/A |
Financial Charts
No financial data available for HUM (annual).
2 superinvestors own HUM
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Dodge & Cox Dodge & Cox | 11,380,673 | $2.0B | 1.09% | 0.0% |
| Richard Pzena Hancock Classic Value | 5,470,982 | $949M | 3.08% | 0.0% |